Literature DB >> 11465247

Doxylamine overdose as a potential cause of rhabdomyolysis.

B Leybishkis1, P Fasseas, K F Ryan.   

Abstract

Doxylamine succinate, an over-the-counter antihistamine, is commonly used as a nighttime sleep aid in the short-term management of insomnia. It is also used in combination with antitussive and decongestant agents for the temporary relief of common cold symptoms. Doxylamine is frequently involved in accidental and intentional overdoses. Rhabdomyolysis and secondary acute renal failure are rare but potentially serious complications, making early recognition and treatment essential. With the large number of nonprescription antihistamines and sleep aids available to the general public, it is important to keep in mind that overdose is a potential problem. The complications associated with overdose of these medications are just as life threatening as those associated with prescription drugs. A high index of suspicion and evaluation of rhabdomyolysis is warranted in antihistamine toxicity. We report an observation of severe rhabdomyolysis associated with doxylamine overdose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465247     DOI: 10.1097/00000441-200107000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Case files of the medical toxicology fellowship at Drexel University. Rhabdomyolysis and compartment syndrome following acute diphenhydramine overdose.

Authors:  David Vearrier; John A Curtis
Journal:  J Med Toxicol       Date:  2011-09

2.  How do pharmacists respond to complaints of acute insomnia? A simulated patient study.

Authors:  Carly Kippist; Keith Wong; Delwyn Bartlett; Bandana Saini
Journal:  Int J Clin Pharm       Date:  2011-03-12

3.  Extreme Elevation of Creatine Kinase in a Young Male Patient With Recurrent Rhabdomyolysis.

Authors:  Layla Al Bizri; Anh Do; Daniel R Ouellette
Journal:  Cureus       Date:  2022-05-07

4.  Massively elevated creatine kinase levels in antihistamine-induced rhabdomyolysis.

Authors:  Karan N Ramakrishna; Amish Shah; Carlos D Martinez-Balzano
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-11-19

5.  Acute renal failure caused by pheniramine maleate induced rhabdomyolysis: an unusual case.

Authors:  G Paul; P Sood; B S Paul; S Puri
Journal:  Indian J Crit Care Med       Date:  2009-10

6.  Pheniramine Maleate-Induced Rhabdomyolysis and Aki: Is it Fatal?

Authors:  K Venugopal; M Mallikarjun Reddy; M Y Bharathraj; Kadappa Jaligidad; D P Kushal
Journal:  Toxicol Int       Date:  2014 Sep-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.